Internal Use
Documents for internal usage
These materials have been created for your convenience as a go-to quick source of information. Please note they are intended only for internal use.
Internal documents
Product training manual
- First part of the presentation provides brief introduction of company MEDICEM, followed by overview of DILAPAN-S and IOL (induction of labour) market. Second part offers you an example of 2022 European communication strategy, incl. unmet needs and DILAPAN-S key benefits.
A UK economic model
- A health-economic model evaluating the cost and staff time of induction of labour with DILAPAN-S to Propess. Published in 2022. Please feel free to download full study and executive summary with key outcomes.
COMRED trial
- A multi-center, randomised controlled trial of 307 women comparing DILAPAN-S to low dose 25 mcg oral misoprostole. Published in 2022. Please feel free to download the full study and executive summary with key outcomes.
SOLVE trial
- A multi-center, randomised controlled trial of 674 women comparing DILAPAN-S to Propess (dinoprostone vaginal insert). Published in 2022. Please feel free to download the full study and executive summary with key outcomes.
DILAPAN-S messaging
- The document overviews key take away messages of DILAPAN-S clinical trials and other publications related to induction of labour. Second part offers you examples of messages you can use to communicate DILAPAN-S benefits.
DILAFOL trial
- A single-center, randomised controlled trial of 419 women comparing DILAPAN-S to Foley balloon. Published in 2019. Please feel free to download full study our executive summary with key outcomes.
HOMECARE trial
- A multi-center, randomised controlled trial of 339 women comparing DILAPAN-S outpatient to inpatient cervical ripening. Published in 2022. Please feel free to download the full study or executive summary with key outcomes.
